Mission Therapeutics raises £60m to advance novel ‘DUB’ drug platformUK biotech company Mission Therapeutics has raised £60 million to invest into its drug discovery and development programme. Share XMission Therapeutics raises £60m to advance novel ‘DUB’ drug platformhttps://pharmaphorum.com/news/mission-therapeutics-raises-60m-to-advance-novel-dub-drug-platform/
